Quote | Generation Bio Co. (NASDAQ:GBIO)
Last: | $3.26 |
---|---|
Change Percent: | -1.78% |
Open: | $2.86 |
Close: | $3.26 |
High: | $3.4 |
Low: | $2.8275 |
Volume: | 213,457 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Generation Bio Co. (NASDAQ:GBIO)
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting preclinical data from its cell-targeted lipid nano...
CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a...
Message Board Posts | Generation Bio Co. (NASDAQ:GBIO)
Subject | By | Source | When |
---|---|---|---|
Generation Bio Co. (Nasdaq: GBIO), an innovative genetic | crudeoil24 | investorshub | 06/12/2020 5:19:44 PM |
Generation Bio Co. is a genetic medicines company. | crudeoil24 | investorshub | 06/12/2020 5:18:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Generation Bio Co. Company Name:
GBIO Stock Symbol:
NASDAQ Market:
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (NASDAQ:GBIO) a biotechnology company innovating genetic medicines for p...
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting preclinical data from its cell-targeted lipid nano...
CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (NASDAQ:GBIO) a biotechnology company innovating genetic medicines for p...